Tag: Carolyn Dillon
Phebra partners with University of Wollongong to develop drug for leukemia, pancreatic cancer
Australian pharmaceutical firm Phebra and the University of Wollongong (UOW) have entered into a six-year collaboration agreement to carry out research and development (R&D) and trials of patented and targeted arsenic compounds for the treatment of acute myeloid leukemias and pancreatic cancer.
Featured Article
Forecasting the future: GridBeyond’s new tool supports smarter energy planning
As Australia’s energy landscape grows more dynamic, businesses operating in the National Electricity Market (NEM) face increasing challenges – from rising costs and evolving regulations to the growing presence of decentralised and renewable energy sources.
